NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III Sells 13,180 Shares

NeueHealth, Inc. (NYSE:NEUEGet Free Report) CEO George Lawrence Mikan III sold 13,180 shares of the firm’s stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $6.93, for a total transaction of $91,337.40. Following the completion of the sale, the chief executive officer now owns 297,790 shares in the company, valued at approximately $2,063,684.70. The trade was a 4.24 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

George Lawrence Mikan III also recently made the following trade(s):

  • On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The stock was sold at an average price of $7.06, for a total value of $11,324.24.
  • On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The shares were sold at an average price of $7.19, for a total value of $191,685.40.
  • On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total transaction of $233,079.34.
  • On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total transaction of $70,236.54.

NeueHealth Price Performance

Shares of NEUE opened at $6.75 on Friday. NeueHealth, Inc. has a one year low of $3.79 and a one year high of $7.66. The company has a market cap of $55.96 million, a PE ratio of -0.13 and a beta of 0.56. The firm has a 50-day moving average of $7.30 and a 200-day moving average of $6.00.

Hedge Funds Weigh In On NeueHealth

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Northern Trust Corp boosted its stake in NeueHealth by 66.8% in the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after purchasing an additional 13,074 shares during the period. Virtu Financial LLC acquired a new stake in shares of NeueHealth during the 4th quarter worth approximately $76,000. Finally, Partners Group Holding AG bought a new position in shares of NeueHealth in the 3rd quarter valued at $463,000. 63.88% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada decreased their target price on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research report on Monday, December 9th.

Get Our Latest Research Report on NEUE

NeueHealth Company Profile

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Further Reading

Insider Buying and Selling by Quarter for NeueHealth (NYSE:NEUE)

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.